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Abstract
Aims: To investigate Group B Streptococcus (GBS) colonization in pregnancy; adherence to antenatal GBS screening and adherence to the intrapartum antibiotics protocol within two models of care (midwifery and non-midwifery led).
Design: This retrospective quantitative study has employed a descriptive design using
administrative health data.
Methods: Data from five maternity hospitals in metropolitan and regional Western
Australia that included 22,417 pregnant women who gave birth between 2015 and
2019 were examined, applying descriptive statistics using secondary data analysis.
Results: The study revealed an overall GBS colonization rate of 21.7% with similar rates
in the different cohorts. A lower adherence to screening was found in the midwifery led
model of care (MMC, 68.76%, n = 7232) when compared with the non-midwifery led
model of care (NMMC, 90.49%, n = 10,767). Over the 5 years, screening rates trended
down in the MMC with stable numbers in the counterpart. Adherence in relation to intrapartum antibiotic prophylaxis revealed discrepant findings between the study groups.
Conclusion: Adherence to screening and management guidelines of maternal GBS
colonization in pregnancy is lower within the MMC when compared with the NMMC.
Impact: This is the first cohort study to describe the adherence to the recommended
Western Australian GBS screening guidelines in the two different models of care. Findings
may assist in the guidance and improvement of clinical protocols as well as the planning
of clinical care in relation to GBS screening to reduce the risk of neonatal GBS infection.
KEYWORDS

adherence, Group B Streptococcus, intrapartum antibiotic prophylaxis, midwifery led model
of care, midwives, neonatal early-onset Group B Streptococcus disease, pregnancy, screening
guidelines

1

|

I NTRO D U C TI O N

of asymptomatic adults (Murray et al., 2016). During pregnancy, GBS
can increase the risk of urinary tract infection, chorioamnionitis, endo-

Group B Streptococcus (GBS) is a fast-growing gram-positive bacte-

metritis and sepsis, featuring as a risk factor for miscarriage, preterm

rium which commonly colonizes the upper respiratory tract, as well

labour and stillbirth (Steer et al., 2020). Typically colonizing a pregnant

as the gastrointestinal and genitourinary tract of approximately 30%

woman's intestinal and/or genitourinary tract, GBS can spread to the

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in
any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
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amniotic fluid, placenta, cervix or vagina (Heath & Jardine, 2014). The

PANGERL et al.

Rao, Nartey, et al., 2017; HogenEsch et al., 2020; Kunze et al., 2015;

foetus can then acquire the bacteria either in-utero via vertical trans-

Yamaguchi & Ohashi, 2018), as well as two Australian studies (Braye

mission during labour (even with membranes intact) or during vaginal

et al., 2019; Moorhead et al., 2019), only one has been identified with

birth (Steer et al., 2020). Invasive Early-Onset Group B Streptococcus

a focus on adherence to GBS screening guidelines specifically within

Disease (EOGBSD), which occurs from 0 to 7 days of life, can result

the midwifery led model of care (MMC) (Yamaguchi & Ohashi, 2018).

leading to serious complications for neonates including meningitis,

Knowledge is limited regarding the comparison of adherence to GBS

pneumonia and neonatal sepsis, where it continues to be a major

screening between pregnant women cared for in different care mod-

cause of morbidity and mortality among term and preterm neonates

els, particularly under the MMC, and those cared for under the non-

(HogenEsch et al., 2020). Neonates who survive a GBS infection can

midwifery led model of care (NMMC). Likewise, to date the comparison

suffer from long-term effects and permanent problems, for example

of screening results between these two models has not been examined.

blindness, deafness, moderate-to-severe neurological impairments and

The objective of this study was therefore to investigate the adherence

cerebral palsy (World Health Organization, 2017). Seale et al. (2017)

to GBS screening and management guidelines including GBS coloniza-

have reported a global disability rate of greater than 10,000 incidents

tion rates, in these two models of maternity care in Western Australia.

of neurological development disorders annually caused by GBS men-

In this paper, maternity care facilitated by midwives as primary caregiv-

ingitis in infants. Worldwide, an estimated 150,000 stillbirths and neo-

ers is referred to as the ‘midwifery led model of care’ while all other care

natal deaths each year are attributed to GBS infection (World Health

options are referred to as ‘non-midwifery led model of care’.

Organization, 2017). In several European countries, for example the
United Kingdom, Ireland, Italy and the Netherlands, an increase of
early-onset GBS infections have been described for the last decades
(De Luca et al., 2016; O'Sullivan et al., 2019). A large retrospective
analysis of data collected from multiple hospitals in Australia and New

2
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2.1 | Aims

Zealand has reported an EOGBSD rate of 0.43/1000 live births with
a mortality rate of 11% (Singh et al., 2019). Preterm neonates are at

The overall aim of this study was to investigate the adherence to

significantly increased risk, amounting to 3% for infection rates and up

the recommended prevention strategy for early-onset neonatal GBS

to 30% of mortality rates (Heath & Jardine, 2014).

infection in Western Australia in pregnant women of the MMC and
the NMMC and was guided by the following objectives:

1.1 | Background

1. To determine the overall and population specific rate of GBS
colonization in pregnancy in all groups under study

Universal GBS screening has been an effective tool for tackling neo-

2. To examine the prevalence of antenatal GBS screening adherence

natal sepsis, where it includes rectovaginal culture swabs between

specific to the MMC group, the NMMC group and subgroups

35 and 37 weeks of gestation to identify women who are colonized

including Midwifery Group Practice (MGP), the Community

with GBS, who then receive intrapartum antibiotic prophylaxis (IAP)

Midwifery Programme (CMP), and the group of Private Midwives

(Hasperhoven et al., 2020). This preventative strategy has led to a
significant reduction in EOGBSD globally and is considered more effective than a risk-based approach where intrapartum antibiotics are

(PM) using electronic administrative birth data
3. To examine the adherence to IAP in all groups under study when
antenatal GBS screening showed a GBS positive result

administered on determination of certain risk factors for EOGBSD
including, prolonged rupture of membranes (≥18 h), a previous
neonate with EOGBSD, GBS bacteriuria or maternal fever (≥38°C)

2.2 | Design

(Hasperhoven et al., 2020). Compelling evidence demonstrates the
negative impact of low uptake of GBS screening on neonatal infec-

Using secondary data analysis, descriptive statistics will be pre-

tion rates (Hasperhoven et al., 2020). In Western Australia (WA), the

sented to systematically examine and identify the patterns and

risk of GBS disease in pregnancy has primarily been managed through

trends of Group B Streptococcus screening and management adher-

recommendations of universal screening at 35 and 37 weeks' gesta-

ence in midwifery and NMMC.

tion, with the administration of prophylactic antibiotics in labour if
the screening result returns positive for GBS colonization or if membranes have ruptured before labour begins (Homer et al., 2014).

2.3 | Sample

Various models of maternity care are available for Western
Australian women, including public hospital care, care from a general

No participants were involved in this study since the data used were

practitioner, private midwife or private obstetrician, shared care and

obtained from electronic health datasets. The population of interest

midwife led care (WA Department of Health, 2019). While there has

for this study was pregnant women whose pregnancy resulted in a live

been international research regarding adherence to antenatal GBS

birth at term (from 37 weeks gestation) and who received antenatal

screening guidelines (Dalmartello et al., 2019; De Luca et al., 2016; Gopal

care in Western Australia from midwifery led and non-midwifery led

|

PANGERL et al.

3249

care providers. The women's age ranged from 13 to 53 years, repre-

adherence in both models of care (midwifery and non-midwifery

senting 169 different countries of birth. Other demographics included

led) over the 5-year period. Further, it was investigated if the de-

the number of pregnancies, which ranged from 1 to 20 as well as the

pendent variable (GBS test result) varied according to subgroups

number of previous livebirths ranging from 0 to 12. Included births oc-

(MGP, CMP, PM). Using the same analytic methods, the adherence

curred in five metropolitan and regional hospitals, a birth centre and

to IAP was examined. Adequate IAP was defined as the initiation of

at home, between 1 January 2015 and 31 December 2019. As given

a recommended dose of antibiotic intravenously at least 4 h prior to

in Table 1, the study population of Hospital 1 included both MMC and

birth (Morgan et al., 2020). Maternal demographics such as women's

NMMC, while the study population of Hospitals 2, 3 and 4 comprised

country of birth, maternal age distribution, gravidity and parity in

the MMC only. The rationale behind this related to the enormous

the two models of care were included in the analysis. Outcomes

number of births of the NMMC group at Hospital 1 (15,268 vs. 11,140

were measured and reported numerically as percentages and counts

of the total number of MMC group of all five hospitals). Data from

and displayed in bar and line graphs to demonstrate proportional

Hospital 5 contained birth records from both models of care as MGP

differences.
Data quality assessment, cleaning and preparation were con-

commenced only in 2017. We excluded women who gave birth before
37 weeks gestation or had an elective Caesarean section.

ducted in numerous steps resulting in a new database with a final
sample size of 22,417 data sets using the software programmes
Microsoft Excel and SPSS Version 26. This involved the develop-

2.4 | Data collection

ment of specific variables to identify non-midwifery and midwifery
led care groups and their subgroups. A detailed description of the

Electronic health data (26,408 data sets) containing information

data quality assessment, cleaning and preparation process can be

about pregnancy and birth were extracted from the database Stork.

sighted on request.

Stork is the clinical perinatal database used by all Western Australian
public health maternity services, including homebirth providers,
to record point-of-care details related to care during pregnancy,

2.6 | Validity, reliability and rigour

birth and the postnatal period (WA Department of Health, 2016).
It is mandatory for caregivers to enter information related to GBS

The exhaustive process of data cleaning, preparing and primary

screening in pregnancy.

analysis in this study ensured that only appropriate variables were

Data included maternal age, gravity, parity, country of birth of

utilized and that the analysis was valid. Descriptive validity is a rela-

the mother, GBS test result and administration of appropriate antibi-

tively new but increasingly popular means of determining the rigour

otic prophylaxis. The GBS status was assigned as positive, negative

of a research project (Bergin, 2018). This type of validity refers to

or pending based on the antenatal GBS culture screening or as not

a provision of detailed and accurate descriptions of how data were

tested where the screening test was not performed and/or declined

collected and analysed, which also can assist in replicating the meth-

by the woman.

ods and results in future research (Bergin, 2018). This study offers
a comprehensive description of the data collection and analysis
processes ensuring its robustness and rigour. This process has been

2.5 | Data analysis

clearly detailed in the research report, providing a trail for any future
research to follow and arrive at the same results using this database,

The GBS colonization and adherence rates of antenatal GBS screen-

further demonstrating the reliability of the work. This transparency,

ing among all women, main and subgroups were identified, where

as Rotelli (2015) advocates, is an important requirement for estab-

distribution and central tendency was investigated. It was examined

lishing strong reliability in retrospective analysis of administrative

whether trending characteristics exist regarding GBS screening

healthcare data.

TA B L E 1 Details of the sample (received data sets, January 2015
–December 2019)
Source

Midwifery led model
of care

Non-midwifery led
model of care

Hospital 1

7074

15,268

Hospital 2

2608

-

Hospital 3

554

-

Hospital 4

833

-

Hospital 5

48

23

Subtotal
Total: 26,408

11,117

15,291

3
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3.1 | Data distribution
The sample of this study comprised data of the two models of care
across five hospitals in metropolitan and regional Western Australia.
The proportion of women receiving midwifery led care was slightly
smaller (46.92%, n = 10,519) compared with 53.08% (n = 11,898) of
women receiving non-midwifery led care. Importantly, the vast majority of data were derived from Hospital 1 with 83.19% (n = 18,648).
The rate for Hospital 2 was 10.71% (2400), which was substantially

3250
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higher than for Hospital 3 with 2.40% (n = 539) and Hospital 4 with

NMMC group. There was little difference with some divergence in

3.39% (n = 759). The smallest proportion of data with 0.32% (n = 71)

women having been born in the South-East Asian region (11.57%,

was identified for Hospital 5. Hospital 1 comprised the two different

n = 1376 vs. 4.59%, n = 483) and European region (16.38%, n = 1723

models, with 36.33% (n = 6773) of women in the midwifery led care

vs. 9.11%, n = 1084). Even smaller was the difference for women with

group and a higher proportion of women receiving non-midwifery led

their birth country grouped in the regions of Americas with 3.27%

care (63.67%, n = 11,875). It was the only hospital representing other

(n = 344) for the MMC and 2.18% (n = 259) for the NMMC. The per-

subgroups of the midwifery led care model which included the MGP

centage of women having been born in the African region was com-

as the largest group among them (81.60%, n = 5527), the CMP with

parable in both groups with 3.37% (n = 355) in the MMC and 5.75%

14.88% (n = 1008), and the group of PM with a small proportion of

(n = 684) in the NMMC. A small contrast was identified when com-

2.49% (n = 168). Seventy records (1.03%) were not analysed across

paring women with the country of birth in the Eastern Mediterranean

these subgroups as they genuinely involved two or more subgroup

region with a low 1.47% (n = 155) in the MMC group versus 6.36%

provider types. This means that 27 records reported women receiv-

(n = 757) in the NMMC cohort. The women's ages ranged from 13 to

ing shared care by the MGP and CMP, while 35 women received care

53 years (M = 30.1). The electronic database did not provide reliable

by MGP and PM, seven women were cared for by the CMP and PM.

information in relation to the socioeconomic status of the women,

One woman was provided maternity care from all three care pro-

such as educational attainment, income, occupation and financial se-

viders. As presented in Figure 1, apart from Hospital 1 and 5, data

curity. A comparison of the maternal age distribution, gravidity and

received from all other institutions referred to midwifery led care

parity in the two models of care revealed no differences.

exclusively, with Hospital 5 providing less than half of their pregnant
population (n = 23/71) non-midwifery led care.

3.3 | Group B Streptococcus colonization

3.2 | Maternal demographics

The GBS colonization rate within this whole Western Australian pregnant cohort who received GBS screening was found to be 21.70%

These data were generated from a diverse cohort of pregnant women

(n = 3907). Comparable rates of GBS colonization were identified in

representing 169 different countries of birth with just over half of

the two care models (Table 2). A small percentage was detected with

the women having been born in Australia (55.52%, n = 12,445). The

GBS results still pending at the time of birth (3.53%, n = 792).

various countries were grouped into six geographic regions according to the WHO's recommendation (WHO, 2021). The African re-

3.4 | Prevalence of adhering to antenatal
GBS screening

gion represented 1039 women (4.63%), the Eastern Mediterranean
region 912 (4.07%), the European region 2807 (12.52%), the region
of Americas 603 (2.69%), the South-East Asia region 1859 (8.29%)
and the Western Pacific region the highest number of 15,186 women

The vast majority of all pregnant women under study had the GBS

(67.74%). For 10 women (0.04%), the country of birth was not avail-

screening test administered (80.29%, n = 17,999), indicating that

able. On comparison, the majority of women of both care models

19.71% of all women (n = 4418) did not receive the screening test.

were born in countries of the Western Pacific region with 70.85%

When comparing the two models of care, remarkable differences

(n = 74.54) of women of the MMC group and 65% (n = 7732) of the

were discovered. In the MMC population (n = 10,519), a low rate

11,875
12,000

Number of Women

10,000
6,773

8,000
6,000
4,000

2,400

2,000
0

539

0

759

0

23 48

0
H1

H2

Non-Midwifery Led Model

H3

H4

Midwifery Led Model

H5

F I G U R E 1 Overview of sample by
model and data source

|
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TA B L E 2 Prevalence of GBS
colonization

3251

Women tested

GBS positive

Study population

n

n

Whole population

17,999

3907

21.70

7234

1470

20.32

10,765

2437

22.63

51

50.1

49.8

34.1

35.5

36.3

13.5

13.2

12.6

1.5

1.1

1.2

2017

2018

2019

Midwifery led model of care
Non-midwifery led model of care

%

Abbreviation: GBS, Group B Streptococcus.

F I G U R E 2 Trends of GBS screening
adherence in the midwifery led model of
care (including screening details). GBS,
Group B Streptococcus

70

62

60

58.1

Percentage

50
40
30

25.2
21.3

20
10

15.6
1.1

0
2015

15.6

1.1
2016

Calendar Year
Positive

F I G U R E 3 Trends of GBS screening
adherence in the non-midwifery led model
of care (including screening details). GBS,
Group B Streptococcus

70

Negative

64.4

63.1

21.8

21.5

8.8

Results Pending

65.9

Not Tested

65.4

63.2

60

Percentage

50
40
30

19.7

20.8

9.5

9.6

10.2

9.5

6

4.8

5.8

6.6

2016

2017

2018

2019

18.5

20
10
0 4.9
2015

Calendar Year
Positive

Negative

Results Pending

Not Tested

of adherence to GBS screening was found (68.76%, n = 7232) com-

Evaluation of the screening trends in antenatal GBS screening

pared with a much higher rate of 90.49% (n = 10,767) in the group of

characteristics over the 5 years for both care provider groups was con-

pregnant women cared for by the NMMC (n = 11,898). This means

ducted (Figures 2 and 3). This revealed a notable increase in the rate of

that 31.24% (n = 3287) of pregnant women in the midwifery led care

the midwifery led women not tested for GBS colonization. In contrast,

model were not tested for GBS colonization in pregnancy, in con-

in the non-midwifery led care model, the rate of women not tested was

trast to 9.50% (n = 1131) in the NMMC.

low, revealing an unremarkable rise. The GBS positive rate was found

3252
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100%

F I G U R E 4 Prevalence of adherence
to GBS screening in midwifery
group practice. GBS, Group B
Streptococcus

96.19%

95.33%
80.14%

80%

62.50%
57.28%

60%
40%
20%
0%
H1

H2

H3

H4

H5

trending low over the years from 15.60% (n = 255) to 12.61% (n = 294)
in the midwifery led care models, and from 21.81% (n = 577) to 18.46%
(n = 419) in the non-midwifery led care group. The rate of women
tested GBS negative was notably declining in the midwifery led models of care while remaining relatively stable in this time period in the

100%
80%

non-midwifery care model. When the pending results were analysed,

60%

a stable rate was observed in the midwifery led group, whereas a slight

40%

uptrend over the years was found in the non-midwifery led cohort.
The exploration of results among the different subpopulations
was of particular importance as vast differences became apparent.
All five hospitals provided the MGP model of care. Among these
MGP groups, the GBS adherence rates and screening details were
examined and contrasted. As this is one midwifery led care provider type, it is surprising that the results of screening adherence

57.30%

48.50%

44.05%

20%
0%

MGP

CMP

PM

F I G U R E 5 Prevalence of GBS screening adherence among
subgroups. GBS, Group B Streptococcus

varied vastly ranging from 57.28% (n = 3166) to 96.19% (n = 730).
For Hospital 1 with the largest number of women in the MGP model

among women of Hospital 2 (95.33%, n = 2288), indicating that a

(n = 5527), the lowest rate of GBS screening adherence was discov-

small 4.67% (n = 112) group of women did not receive GBS screen-

ered. This was followed by a similarly low rate in the small population

ing. While 80.14% (n = 432) in Hospital 3 was the third highest

of Hospital 5. A much higher proportion of pregnant women were

GBS screening adherence rate with 19.86% (n = 107) of women

tested for GBS colonization in the MGP group of Hospital 3. Among

not tested, data revealed a much lower rate for women cared for

all five MGP groups, Hospital 2 and Hospital 4 ranged the highest (all

in Hospital 5 (62.50%, n = 30) with more than a third of women not

details are presented in Figure 4).

receiving the GBS screen (37.50%, n = 18). Surprisingly, the lowest

Among the three subgroups of the MMC (MGP, CMP, and PM)

rate of adherence to GBS screening in this care model was found

at Hospital 1, an interesting trend emerged. The adherence rate

in Hospital 1 (57.28%, n = 3166), indicating that over 40% of this

to screening in the MGP group was found to be remarkably low

cohort was not tested (42.72%, n = 2361). In the non-midwifery

(57.28%, n = 3166), indicating that close to one half of the propor-

led population, a high 90.51% (n = 10,748) of pregnant women in

tion of pregnant women (42.72%, n = 2361) were not tested for GBS

Hospital 1 received GBS screening with 9.49% (n = 1127) not tested,

colonization. However, when these results were compared with the

whereas corresponding findings did emerge for the population of

groups of CMP and PM, they were the highest for the GBS screen-

Hospital 5 in this model of care (82.61%, n = 19 and 17.39%, n = 4

ing adherence. In the CMP cohort, only 48.51% (n = 489) of women

not tested). For these two hospitals, the group average was nearly

underwent GBS testing with 51.49% (n = 519) receiving no GBS test

identical (H1—73%, H5—72.55%) (Figure 6).

in their pregnancy. Notably, an even lower rate of adherence was
identified in the PM population (44.05%, n = 74), which means that
more than a half of this group (55.95%, n = 94/168) missed out on

3.5 | Adherence to IAP

screening for GBS colonization (Figure 5).
Comparing GBS screening adherence rates between the hos-

Among all women under study, 3907 (21.70%) women had an in-

pitals it was found that in the midwifery led models of care rates

dication for IAP due to a GBS positive test result. Investigations of

were the highest in Hospital 4 (96.19%, n = 730) with only 3.81%

adherence to IAP revealed that 73.68% (n = 2879) women were pro-

(n = 29) of women not tested. Similarly, high rates were identified

vided with it. When adherence rates to IAP were compared between

|
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F I G U R E 6 Adherence to GBS
screening based on model of
care and setting. GBS, Group B
Streptococcus

3253

100

PERCENT

80

60

40

20

0
ML N ML

ML N ML

ML N ML

ML N ML

ML N ML

H1

H2

H3

H4

H5

Non-adherence to GBS screening protocol
Adherence to GBS screening protocol
F I G U R E 7 Adherence to intrapartum
antibiotic prophylaxis among midwifery
group practice groups

100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
H1

H2

H3
IAP

H4

H5

No IAP

the two models of care on the numbers of GBS colonized women in

GBS colonization in Hospital 2, of whom 68.45% (n = 293) received

each group (MMC n = 1470, NMMC n = 2437), the results revealed a

IAP with 31.55% (n = 135) of women not being treated. In contrast,

low adherence rate in the MMC group (65.51%, n = 963). This means,

the adherence rates for Hospital 3 were much lower with just over

34.49% (n = 507) of women did not receive antibiotic prophylaxis

half of all GBS positive tested MGP women (n = 72) receiving IAP

in labour. In contrast, in the NMMC cohort, 78.62% (n = 1916) of

(59.72%, n = 43) with similar findings among the 136 women in

women were given IAP, leaving 21.38% (n = 521) without prophy-

Hospital 4 who were treated with prophylactic antibiotics in 53.67%

lactic treatment.

(n = 73). This means that nearly half of the proportion of women

When adherence rates to IAP were compared among the

were not administered IAP in the MGP groups of Hospital 3 and 4

GBS colonized women of the MGP population of all five hospi-

(H3 40.28%, n = 29; H4 46.33%, n = 63). The adherence rate for

tals (n = 1341), enormous differences were revealed with all find-

Hospital 5 with seven GBS positive tested women was extremely

ings below 70%. The GBS positive-tested MGP women in Hospital

low at 28.57% (n = 2), indicating that the majority of these women

1 (n = 698) were administered IAP in 67.33% (n = 470), indicating

missed out on IAP (71.42%, n = 5) (Figure 7).

that 32.66% (n = 228) women did not receive it. In comparison, re-

On further examination, the results of subgroups of the MMC

markably close results were revealed for the 428 MGP women with

in Hospital 1 in relation to adherence to IAP were compared and

|
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revealed varying findings. The highest rate was found in the MGP

between these ecologically distinct population groups (Anderson

cohort with 67.33% (n = 470/698) with 32.66% (n = 228) not cov-

et al., 2020).

ered with antibiotics followed by 63.72%, n = 65) in the group of
CMP which included 102 GBS colonized women, indicating that
36.28% (n = 37) of women did not receive prophylactic antibiot-

4.2 | Adherence to antenatal GBS screening

ics. In stark contrast, in only half of the group of women tested
GBS positive in the PM population (n = 19), IAP was adhered to

The current study found that the adherence rate to antenatal GBS

(52.63%, n = 10) while 47.37% (n = 9) were not provided with an-

screening guidelines was high in the whole population cohort, which

tibiotic prophylaxis.

corroborated previous Australian (Braye et al., 2019; Moorhead
et al., 2019) and international findings (Berardi et al., 2017). The dif-

4
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DISCUSSION

ferences of adherence rates between the two models of care, as well
as the unexpected findings of the discrepancies between the MGP
groups when compared separately for each hospital, were surpris-

This retrospective study has presented a structured investigation of

ing and not comparable to literature due to the lack thereof. This

characteristics of GBS screening adherence plus intrapartum man-

study's results corroborate previous findings in that GBS adherence

agement with antibiotics in two major target groups of pregnant

rates among pregnant women in the MMC were low (Yamaguchi &

women in Western Australia. To the researchers' knowledge, no

Ohashi, 2018). Further, an examination of the 5-year trend in the cur-

study has examined the comparison between the midwifery led and

rent study indicated a decrease in the GBS screening rate of women

the non-midwifery led models of care in this context.

in the midwifery led model, when compared with a stable proportion
in the non-midwifery led care group. This decreased testing raises

4.1 | GBS colonization

important questions as to possible reasons for this trend. There could
be potential professional determinants, such as midwife knowledge
and perspectives, differences in hospital specific acknowledgement

The examination of GBS colonization data across the five hos-

of clinical guidelines, non-
standardized educational material for

pitals revealed an overall rate of 21.70% which was similar to

pregnant women, or factors that include women's knowledge and

average rates in international research (Edwards et al., 2019;

perceptions as well as controversial opinions in regard to prevention

Jisuvei et al., 2020; Ramesh Babu et al., 2017; Szylit et al., 2020)

strategies to avoid neonatal early-onset GBS disease.

and consistent with results of previous Australian studies (Braye
et al., 2019; Furfaro et al., 2019; Moorhead et al., 2019). No studies
were located to relate findings of the current study in relation to the

4.2.1 | Midwives' knowledge and perspectives

different models of care (non-and midwifery led care). However,
differences in GBS colonization rates in the present study between

Midwives, as the lead professional care provider in the MMC, play a

the two care models, and also between each hospital across the

critical role when it comes to adherence to clinical guidelines. Among

large geographical area of Western Australia, were observed, mir-

midwives in this model of care, autonomous practice and women-

roring variations between countries (Kwatra et al., 2016; Shabayek

centred care are highly regarded (Sheehy et al., 2019). Midwives are

& Spellerberg, 2018). These findings indicate that variations oc-

the highest ranked source of information for pregnant women fol-

curred in different ethnic populations across the world with the

lowed by medical personnel and media (McQuaid, Pask, et al., 2016).

highest GBS colonization rate among African women and the low-

By providing information, education and counselling, a midwife sup-

est in the pregnant population of Asia and the Middle East (Gopal

ports women to make informed decisions and promotes woman-

Rao et al., 2019; Shabayek & Spellerberg, 2018). Population dif-

centred care during pregnancy, birth and the postnatal period (Hunter

ferences suggest varying natural immunity of pregnant women to

et al., 2017). This is an important consideration when examining adher-

GBS along with factors such as lifestyle, swab collection methods

ence to GBS screening guidelines in pregnancy, because the informa-

and laboratory techniques which can also contribute to different

tion the woman receives from the midwife can significantly contribute

GBS colonization rates (Ashary et al., 2020; Furfaro et al., 2019;

to her decision making for or against the test. Consequently, a mid-

Lao, 2019). Underlying population differences in the natural im-

wife's knowledge and approach to GBS screening remarkably affects

munity of pregnant women to GBS may explain the different GBS

and guides a woman's decision. Knowledge about GBS in pregnancy

colonization rates in the current study. Various factors may affect

among midwives can differ, as highlighted by one group of parents

the maternal immune system including anthropometric measures

that stated that health professionals did not seem well informed about

and racial background (Lao, 2019). Different immune responses

this topic (McQuaid, Jones, et al., 2016). Considering the low adher-

occur in women of high-income countries, compared with women

ence rate to GBS screening in the MMC in the current study, possible

from non-
industrialized population groups, over the course of

specific education of midwives to improve adherence to the recom-

pregnancy, including pro and anti-
inflammatory processes pos-

mended GBS screening guidelines in Western Australia may be an ef-

sibly due to contrasting immunological demands in pregnancy

fective intervention. In this regard, Pangerl et al. (2021) in their review
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of the literature have demonstrated that implementing educational

indicating that the more the care was detached from hospital en-

measures into the clinical practice of health professionals can result in

vironments, the lower the screening rate. It can be speculated that

an increase in antenatal GBS screening rates. The knowledge and per-

explanations offered above may have influenced the findings. In ad-

spectives of midwives in relation to GBS screening guidelines might

dition to the recognition of clinical guidelines, different educational

also be impacted by their backgrounds.

strategies informing pregnant women about GBS in pregnancy may

The midwifery workforce in Western Australia comprises of

influence maternity care.

midwives from all around the world. Midwives possess vastly different backgrounds including variations in midwifery qualifications,
scope of practice, midwife to women ratios, professional autonomy,

4.2.3 | Educational strategies during antenatal visits

culture and practice differences (Philip et al., 2019). The specific
imprint of work experience in the country of qualification may influ-

The provision of non-s tandardized education material and meth-

ence clinical practice in Western Australia. For example, midwives

ods across the different population groups might be another

trained in the United Kingdom, where antenatal GBS screening is

contributing factor to dissimilar screening adherence rates in the

not common practice, may have different viewpoints as compared

present study. Antenatal care is provided in various settings includ-

with midwives from countries with GBS screening guidelines such as

ing hospitals, outpatient care centres and at home by midwives

the USA. Further, the recognition of clinical GBS practice guidelines

and obstetricians using differing educational strategies to inform

by midwives is integral in providing quality care with the aim of best

pregnant women, aiming for the best maternal and neonatal health

health outcomes for women and their newborns.

outcomes. Multiple formats for conveying antenatal education to
pregnant women can be utilized such as explanatory booklets, face-
to-face information, group information sessions, videos and health

4.2.2 | Recognition of clinical guidelines

apps. Admittedly, it can be challenging for health professionals to
communicate the same information in all the different formats. For

The current study does not provide direct evidence as to differences

example, parents who were affected by GBS infection previously,

in how clinical guidelines have been recognized at each hospital.

voiced the importance of adequate antenatal education in relation

However, it is possible that adherence to clinical guidelines may ex-

to GBS, as they felt it was not provided to themselves (McQuaid,

plain discrepancies in adhering to GBS screening guidelines in the

Pask, et al., 2016). In the current multi-centre study, antenatal care

present study. Evidence-based clinical guidelines ensure best prac-

was conducted in multiple ways and settings. While it could not

tice and optimal quality of clinical care for maternal and neonatal

be evidenced from the data, it is reasonable to assume that differ-

health; therefore, adherence to these standards is an essential part in

ent methods were used, resulting in different GBS screening rates.

the scope of practice of health professionals (Millington et al., 2020).

Therefore, a standardized and regulated antenatal education sys-

Notably, adherence rates to GBS screening guidelines in the MGP

tem, providing women with equal opportunities for a well-informed

cohort in the current study were lowest at a tertiary hospital, where

decision may need to be developed. Further, pregnant women's

Western Australia GBS screening guidelines were initiated and found

knowledge and perceptions are important in relation to adherence

the highest in the hospital furthest away from metropolitan Western

to GBS screening.

Australia. These findings are inconsistent with an analysis of adherence to other clinical guidelines in a multi-centre study (Millington
et al., 2020). It is possible that the importance of the recommended

4.2.4 | Women's knowledge and perceptions

Western Australia GBS screening guidelines was acknowledged and
interpreted differently in each hospital, which may be rooted in the

Women's knowledge and perceptions in relation to GBS screening

personal commitment of midwives to professional accountability

should be considered. In contemporary Western culture, women un-

and ownership (Sherman & Cohn, 2019).

derstand pregnancy and childbirth rather subjectively, incorporating

Professional accountability in health care requires compliance

their individual circumstances and unique situations including level of

with workplace protocols and ethical standards. Differences in prac-

education, previous childbearing experiences and place of residence

tice patterns of health professionals may be explained by a lack of

(Lee et al., 2019). Empirical evidence suggests that the knowledge of

understanding of workplace protocols and procedures (Sherman &

women concerning GBS in pregnancy and the associated risk of neo-

Cohn, 2019). Further, adherence to clinical protocols may be eval-

natal infection is generally poor (Alshengeti et al., 2020; McQuaid,

uated more or less consistently at various hospitals and possibly

Jones, et al., 2016; McQuaid, Pask, et al., 2016). Differences in

with different levels of standards for accountability, responsibility

knowledge between women in their first pregnancy compared with

and ownership of clinical guidelines, which may be influenced by

women with previous pregnancies have been observed (McQuaid,

the leadership or management of the specific health care facility

Jones, et al., 2016), which may have contributed to variations in GBS

(Hegarty et al., 2019). The current study's adherence rates to GBS

screening adherence in the present study. Furthermore, controver-

screening guidelines dwindled further when subgroups of the mid-

sial views among maternity care professionals may explain the ob-

wifery led care model (MGP, CMP, PM) were examined separately,

served differences.
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Some women who tested GBS positive in the third trimester
were not colonized with GBS at the time of birth, indicating that they

The discrepancies in findings of the current study about adherence

needlessly received prophylactic antibiotics (Plainvert et al., 2017).

to recommended prevention guidelines may be a result of differ-

Other women did not receive intrapartum prophylactic antibiotics

ent views among health professionals, reflecting a long ongoing

as a result of a GBS negative result in pregnancy, while antibiotics

debate about which prevention approach should be adopted (Rao

were required because the GBS status changed to positive at birth

& Khanna, 2020). Various observational studies have examined and

(Virranniemi et al., 2019). To minimize this problem, the Centers for

compared the effectiveness of both prevention strategies, finding a

Disease Control and Prevention (CDC) adjusted their recommenda-

significant reduction of neonatal early-onset GBS disease when the

tions of the time of the screening from 35–37 to 36–37 weeks and

universal GBS screening approach is used (Al Luhidan et al., 2019;

6 day's gestation to avoid a decrease of the predictive value of the

Gopal Rao, Townsend, et al., 2017; O'Sullivan et al., 2019; Shabayek

test (CDC, 2020). A further disadvantage of antenatal screening

& Spellerberg, 2018). Importantly, the discontinuation of antena-

relates to long laboratory processes, taking approximately 72 h to

tal GBS screening was found to be significantly associated with an

yield a result, which may result in GBS-colonized women not hav-

increase in rates of neonatal early-onset GBS disease (Al Luhidan

ing antibiotics administered if preterm labour occurs (Carrillo-Ávila

et al., 2019). Further, health care providers adopting the GBS screen-

et al., 2018). In recent years, international research has examined

ing approach have argued that approximately 50% of women whose

the development of a more efficient method for timely detection

neonates developed early-onset GBS disease did not display any risk

of GBS, resulting in trialling rapid Polymerase Chain Reaction test

factors including GBS bacteriuria, neonatal early-onset GBS disease

methods, which is hoped to provide a faster alternative (Carrillo-

following previous births, prolonged rupture of membranes, preterm

Ávila et al., 2018; Fullston et al., 2019).

labour or pyrexia in labour, decreasing the potential effect of the risk-
based approach (Gopal Rao, Townsend, et al., 2017; Hasperhoven
et al., 2020). This is a significant number of women without risk fac-

4.3 | Adherence to IAP

tors whose neonates developed early-onset GBS disease, indicating
that a large number of neonatal infections could not be prevented

Across the entire population of the current study, close to three

using the risked-based approach. In contrast, results from findings in

quarters of women were administered IAP where it was indicated

other studies have shown that the risk-based approach can be effec-

by a positive GBS screening result, which is comparable to previ-

tive in reducing neonatal early-onset GBS disease or keeping these

ous research (Braye et al., 2019; Gopal Rao, Nartey, et al., 2017;

rates stable (Braye et al., 2019; Chen et al., 2019).

Moorhead et al., 2019). The discrepancies in adherence rates to IAP

Practitioners favouring the antenatal GBS screening approach

guidelines between the two models of care, MGP groups at each

highlight the high quality of counselling of women who are GBS col-

hospital and subgroups, were again not able to be related to con-

onized, whereby the screening approach allows adequate time to

temporary literature due to lack of existing studies. However, these

discuss implications and options for management as opposed to the

findings reflect variations in international studies with relatively high

risk-based approach (Steer et al., 2020). Further, as there are scarcely

adherence rates (Braye et al., 2019; Gopal Rao, Nartey, et al., 2017;

time constrains when screening for GBS between 35 and 37 weeks

Kunze et al., 2015; Moorhead et al., 2019) and opposed findings of

gestation, susceptibility testing in case of a penicillin allergy can be

low rates (Yamaguchi & Ohashi, 2018). While adherence rates in the

conducted in women with a positive test result (Steer et al., 2020).

current study were higher in the NMMC when compared with the

The diagnosis with GBS colonization may cause dissonance for many

MMC, remarkably low rates were identified in the groups of the CMP

women and affect their whole experience of pregnancy, labour and

and PM, and the lowest in a MGP cohort of one regional hospital.

birth (Sharpe et al., 2015). In this regard, concerns of women and their

This finding is consistent with research undertaken in the MMC by

partners have included: aspects of the woman's and neonate's health;

Yamaguchi and Ohashi (2018). Whereas these results cannot show

potential risks, as well as implications of birth plans; the normal con-

contextual influences, possible reasons for this may include missed

cept of birth within the MMC; and even the unease regarding the

opportunities, knowledge gaps, and, as discussed above, controver-

competence of midwives (Sharpe et al., 2015). When women were in-

sial views among midwives in the MMC. Further, concerns regarding

terviewed about the way the GBS positive result was communicated,

overuse of antibiotics and their possible adverse effects on the neo-

the group of women who were given the information by the midwife

natal microbiome are contemporary issues that are discussed below.

via telephone indicated their worry and fear and stated that these
feelings could have been avoided with the provision of the test result
in person (Sharpe et al., 2015). Those findings suggest that the antenatal screening approach allows sufficient time for discussing the

4.3.1 | The question of overusing antibiotics and its
adverse effects

GBS topic and its implications, which is crucial for women in making
an informed decision. Another factor that invoked controversial de-

Health professionals continue to argue that antibiotics should be used

bate was limitations regarding universal culture screening in relation

wisely, particularly in the light of the growing concern of antibiotic

to the intermittent nature of GBS (Plainvert et al., 2017).

resistance globally. In the context of invasive neonatal GBS infection,
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intrapartum antibiotic administration has been shown to reduce this

the MMC when compared with pregnant women in the NMMC.

risk by approximately 80% when combined with the antenatal screen-

This also includes the adherence to the protocol of administering

ing approach (Morgan et al., 2020). Against this background, health

IAP when indicated by a positive GBS screening result. Thus, it

professionals need to balance the risks of women receiving prophy-

may be proposed that the MMC may reflect differing knowledge

lactic antibiotics with the GBS screening strategy, compared with a

and perspectives of midwives which may impact on the adherence

risk-based approach of refraining from the provision of antibiotics, to

to GBS screening and management guidelines. Further, it appears

determine which approach should be implemented. In this regard, a

that the concern of medicalisation of birth—in particular in the low-

wide range of evidence should be considered, such as the meta-analysis

risk pregnancy population—is an influencing factor in this regard.

by Hasperhoven et al. (2020), who found no association between using

Additionally, it seems that pregnant women lack knowledge in rela-

the screening approach and an increased use of antibiotics.

tion to implications of GBS colonization in pregnancy, which may be

The literature has reported a clear risk of adverse effects includ-

a result of non-s tandardized antenatal education across maternity

ing alterations to the foetal microbiome and antimicrobial resistance

care providers in Western Australia. Further conclusions can be

following antibiotic exposure (Seedat et al., 2017). However, consid-

drawn regarding growing concerns of antibiotic overuse and pos-

eration should be given to evidence suggesting that while antibiotic

sibly resulting adverse effects impacting GBS screening adherence.

use can decrease the count of healthy Bifidobacterium in the micro-

Furthermore, specific GBS screening and management protocols

biome of the neonate within the first 7 days of life, this count nor-

may be recognized differently in their importance between mater-

malizes at 4 weeks (Corvaglia et al., 2016). Furthermore, long-term

nity hospitals and are evaluated to a greater or lesser extent.

effects, such as increased body mass index in early childhood, were

It is recommended that multifaceted educational interventions that

not found to be associated with the use of GBS-specific antibiotic

are aimed at improving adherence to GBS screening guidelines and clin-

prophylaxis (Metz et al., 2020). Another concern is the adverse ef-

ical practice for midwives are implemented. These may include regular

fect of antibiotic resistance (Seedat et al., 2017). With intravenous

handover meetings, on-line learning modules, workshops or webinars

penicillin as the first line of antibiotics followed by cefazolin and

targeted at optimizing specific knowledge in relation to GBS in pregnancy

vancomycin (in cases of adverse reactions to penicillin) to prevent

and strengthening communication skills for obtaining an informed con-

neonatal early-onset GBS disease (Morgan et al., 2020), reports of

sent for routine antenatal GBS screening. Regular evaluation of adher-

microbial resistance particularly to the latter two antibiotic types

ence to GBS screening guidelines in maternity care settings could be the

have been documented (Hayes et al., 2020; Seki et al., 2015). While

follow-up strategy to maintain improved adherence levels.

penicillin-resistant GBS have been detected in Japanese patients'

It is recommended that antenatal education in relation to GBS

respiratory isolates, they were not isolated in maternal or neonatal

in pregnancy be standardized for all maternity care providers across

GBS strains (Seki et al., 2015). Until now, GBS is susceptible to pen-

Western Australia. Standardized educational material has the advan-

icillin however, it cannot be predicted if and when GBS develops re-

tage of offering a coherent and complete set of information to every

sistance to penicillin, highlighting the importance of microbiological

pregnant woman and may include the provision of equal sources of

stewardship (Hayes et al., 2020). To date, information about adverse

information such as pamphlets, posters and face-to-face sessions.

effects following intrapartum GBS prophylaxis appears conflicted.

Standardized antenatal GBS education will ensure that pregnant

Further research is required to examine the different positions and

women receive the same information for making an informed de-

investigate effects in longitudinal studies.

cision in relation to antenatal GBS screening for the prevention of
neonatal infection. This strategy could inform clinical practice guide-

4.4 | Limitations

lines across Western Australian maternity care providers to ensure
effective implementation.
Further research in a qualitative capacity is needed to examine

This study was limited to descriptive statistics and did not exam-

possible reasons why adherence rates are low in the MMC.

ine correlations between specific demographic characteristics, GBS
colonization and adherence rates. Further, due to the lack of infor-
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mation it could not be established whether the GBS swab collec-
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